AGS3 Polyclonal Antibody

Rabbit Anti-AGS3 Polyclonal Antibody

Product Specifications

Background

G-protein signaling modulators (GPSMs) play diverse functional roles through their interaction with G-protein subunits. GPSM1 encodes a receptor-independent activator of G protein signaling, which is one of several factors that influence the basal activity of G-protein signaling systems. The G-protein signaling modulator 1 contains seven tetratricopeptide repeats in its N-terminal half and four G-protein regulatory (GPR) motifs in its C-terminal half. Multiple alternatively spliced transcript variants encoding different isoforms have been found for GPSM1.

CAS Number

9007-83-4

Product Name Alternative

GPSM1; AGS3; G-protein-signaling modulator 1; Activator of G-protein signaling 3

Gene ID

26086

Accession Number

Q86YR5

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from the Internal region of human AGS3

Clonality

Polyclonal

Tag

G-protein-signaling modulator 1

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

AGS3 Polyclonal Antibody detects endogenous levels of AGS3 protein.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:5000; IF 1:50-200